EXPERIMENTAL study of the relation of isoniazid to carcinogenesis takes its origin from human pathology and this is an index of the timeliness of the research and of the seriousness of the problem, which was posed by the Hungarian school (Berencsi et al., 1952; Juhasz et al., 1957) . The root of experimental research should always be this: experimental pathology not as an end in itself (as is often the case) but having a starting-point, which is the human disease, and an objective, which is the solution of the problems inherent in diseases in man (Severi, 1965 months and they kept 50 as controls. In 310% of the treated mice which lived beyond 71 months, neoplasms of the lungs and the lymph nodes were present, while the incidence of neoplasms in the controls was almost insignificant (2 %). Yasuno (1959) and Mori et al. (1960) reported that this chemical was carcinogenic for another substrain of mice; they, in fact, obtained pulmonary tumours in " dd " mice which lived more than 71 months after the start of treatment of 3 to 4 months' duration, with INH added to the diet. The Japanese workers also observed a relationship between the amount of drug and the incidence of neoplasms, which dropped from 100% to 70%, to 60%, to 50% and to 8% when the INH dose was cut progressively from 0-25 to 0-125, to 0410, to 0-06 and to 0-001% of the diet. The subcutaneous administration of INH was equally effective.
THE RELATION OF ISONIAZID (INH)
Received for publication March 28, 1966 EXPERIMENTAL study of the relation of isoniazid to carcinogenesis takes its origin from human pathology and this is an index of the timeliness of the research and of the seriousness of the problem, which was posed by the Hungarian school (Berencsi et al., 1952; Juhasz et al., 1957) . The root of experimental research should always be this: experimental pathology not as an end in itself (as is often the case) but having a starting-point, which is the human disease, and an objective, which is the solution of the problems inherent in diseases in man (Severi, 1965) . Berencsi et at. (1952) were the first to bring under consideration the enhancing effect of isonicotinic acid hydrazide or isoniazid (INH) on the growth of a neoplasm: because of a diagnostic error, they administered about 7-7 g. of INH to a 33-yearold man with a pulmonary tumour, and noted that the clinical course was extremely rapid owing to precocious, numerous and voluminous metastases.
Pompe showed in 1956 that the cancerous development of Lupus vulgaris increased after the introduction of INH therapy from 0 5% to 4-6%. Randazzo (1959) , who had already reported a case of cutaneous tuberculosis treated with INH which had developed into carcinoma (Randazzo, 1954) , makes the point that these contributions do not permit a possible relationship between this chemical and cancer to be completely ruled out.
INH and Hydrazine in Mice
Juhasz et al., in 1957, used 95 albino mice about 2 months old; they injected 45 of them intraperitoneally with 1 mg. of INH per day for a period of about 3 months and they kept 50 as controls. In 310% of the treated mice which lived beyond 71 months, neoplasms of the lungs and the lymph nodes were present, while the incidence of neoplasms in the controls was almost insignificant (2 %). Mori and Yasuno (1959) and Mori et al. (1960) reported that this chemical was carcinogenic for another substrain of mice; they, in fact, obtained pulmonary tumours in " dd " mice which lived more than 71 months after the start of treatment of 3 to 4 months' duration, with INH added to the diet. The Japanese workers also observed a relationship between the amount of drug and the incidence of neoplasms, which dropped from 100% to 70%, to 60%, to 50% and to 8% when the INH dose was cut progressively from 0-25 to 0-125, to 0410, to 0-06 and to 0-001% of the diet. The subcutaneous administration of INH was equally effective.
Schwan treated RIII mice with intraperitoneal INH in two experimental investigations; in the first (1961) he administered 2-50 mg. of INH per day for 274 days, in the second (1962) 1-25 mg. per day for 87 days. The incidence of pulmonary tumours was, respectively, 25% and 37%; it was nil in the controls. Biancifiori and Ribacchi (1962a, b) began their research in this field in 1959: INH and hydrazine were administered by stomach tube, so that the exact dose would be known and also so as to use the same route by which these drugs are normally introduced into human beings (Severi, 1961 (Severi, , 1964a .
It has been shown that in animals INH breaks down into isonicotinic acid and hydrazine (H2N-NH2) which, in its turn, might be transformed into ammonia (Porcellati and Preziosi, 1954; Toida, 1962) . Hydrazine, therefore, represents the principal metabolite of INH. Biancifiori and Ribacchi (1962a, b) administered 2 mg. of INH per day and equimolecular doses of hydrazine sulphate (1.13 mg.) and sodium salt of isonicotinic acid (1.30 mg.), respectively, to three groups of female BALB/c/Cb/Se substrain mice; the treatment was continued for more than 46 weeks, when all the mice were killed. In the first two groups, that is, those treated with INH and hydrazine, all the mice had pulmonary tumours, while in the third grouptreated with sodium salt of isonicotinic acid-lung tumours were present in only 19% of the animals.
The average number of pulmonary tumours per mouse with tumours was 4 after INH, 18 after hydrazine sulphate and 1 after sodium salt of isonicotinic acid. Histologically they were classified as adenomas (solid and papillary), adenomas becoming malignant, and carcinomas; their incidence was, respectively, 93, 4 1 and 2.7 % of the mice treated with INH and 96, 2-2 and 1.7 % of the mice treated with hydrazine. The tumours observed in mice treated with sodium salt of isonicotinic acid were all adenomas.
The results obtained suggested the possibility, as stated above, that the tumours observed after INH administration to the mouse were due, principally, to the liberation of hydrazine. In agreement with this pathogenic concept Clayson (1962) observes that "... if this is confirmed, chemicals which are capable of liberating hydrazine in the tissues must be regarded as potential carcinogens to man In order to confirm this possibility, Biancifiori et al. (1963b) treated BALB/c/Cb/Se and BALB/c/An/Se substrain mice with hydrazine sulphate (1-13 mg. per day). The experiment also had the aim of establishing the induction time for pulmonary tumours, and studying the resulting morphological changes with respect to the different survival period after the introduction of an identical quantity of hydrazine. The induction time ranged around 150 days (after the 200th day the percentage of these pulmonary tumours was not far from 100%0), the incidence of the more malignant forms rose in relation to the quantity of hydrazine administered and with the longer survival time of the mice. With regard to the previous experiments of Biancifiori and Ribacchi (1962a, b) , in this experiment the percentage of anaplastic adenomas* and of carcinomas rose, respectively, from 2.2o% and 1.7o% to 13.47o% and 7.07o%. The greater concentration of these two neoplastic types occurred in mice which died after the 310th day of treatment, when the administration of hydrazine was discontinued. This shows that, among the various pulmonary tumours induced in BALB/c/Cb/Se and BALB/c/An/Se * Anaplastic adenoma : with this term Biancifiori et al. (1963b) included those adenomas that in other circumstances (Biancifiori and Ribacchi, 1962a, b) In all the CBA/Cb/Se substrain mice in this experiment, the majority of the anaplastic adenomas and carcinomas were found in the animals surviving the longest, when the treatment had been discontinued for several weeks. In this respect, therefore, this substrain of mice behaved in relation to INH and hydrazine like the BALB/c/Cb/Se and BALB/c/An/Se substrains, with and without mammary tumour virus (MTV) (Biancifiori et al., 1963b; Ribacchi et al., 1963) . This progression towards malignancy in pulmonary tumours induced by INH and hydrazine contrasts with Cowen's observations (1947) in C57B1 mice treated with urethane. It would seem, in fact, that pulmonary tumours induced by urethane in these mice had the tendency to regress after the treatment was discontinued. This has been attributed to the low incidence of spontaneous pulmonary tumours in the C57B1 substrain. The CBA/Cb/Se substrain also has a low spontaneous incidence of these neoplasms (Biancifiori et al., 1963a) but in these mice, along with a considerable increase in the percentage of pulmonary tumours, the progression of these towards malignancy in mice surviving after the 36th week of life has also been noted (Biancifiori et al., 1963a) , that is, after the treatment had been interrupted. This might give rise to the idea that the carcinogenic potential of INH and hydrazine in these mice is greater than that of urethane. This hypothesis is confirmed also by observations concerning the morphological and biological characteristics of pulmonary tumours induced in CBA mice by urethane. Nettleship et al. (1943) , in fact, reported that these tumours showed no evidence of invasion and did not metastasize. In CBA/Cb/Se substrain mice treated by Biancifiori et al. (1963a) , however, 4 pulmonary carcinomas metastasized, one (in a female treated with INH) to the kidneys and three (in females treated with hydrazine) to the paratracheal lymph nodes. In several treated mice adrenal alterations, characterized by hyperplasia and brown degeneration, were also found.
Moreover, the interest in this research lies in the fact that hydrazine sulphate induced hepatomas as well, in 620% of the males and in 710% of the females still alive from 20 to 99 weeks after the start of the treatment (Biancifiori et al., 1964a; Severi, 1964b Metastases were not found. Biancifiori and Ribacchi (1962a, b) did not observe spontaneous pulmonary tumours in female BALB/c breeding mice, the majority of which died before the 79th week. When, however, BALB/c/Cb/Se virgin mice were kept in conditions identical with those of the treated mice, 27 % of the females and 210% of the males developed spontaneous pulmonary tumours. Of these, 2 tumours appeared before 79 weeks. the other 9 between 80 and 99 weeks (Biancifiori et al., 1964a) . It may be concluded, therefore, that this substrain has a low incidence of spontaneous pulmonary tumours in aged mice, and that for an adequate control on the experimental mice, survival must be equal in the two groups. Siegel and Iwainsky (1960a) reported that the administration of INH to mice into which Ehrlich's ascites tumour was introduced intravenously lessened the metastasizing of it in the various organs. The same authors (1960a, b) and Siegel (1962) showed that if the drug is administered after the transplantation of the tumour, it grows regularly; if, on the other hand, INH precedes the transplantation, the neoplastic development is inhibited. Biancifiori et al. (1966) (Biancifiori et al., 1963a) . Almost identical histological patterns have been described by other research workers in the lungs of mice treated both with urethane and with INH, and defined as ". . . earliest stages of tumour formation " (Selbie and Thackray, 1948) , " earliest lesions " (Nettleship et al., 1943) , " foci of increased cellularity " (Mostofi and Larsen, 1957) and " hypercellularity areas " (Mori and Yasuno, 1959) .
According to Milia et al. (1964) the myeloid leukaemias observed in mice treated with 4-INIP are to be attributed to the relative stability of the hydrazinic group in this chemical, because of which hydrazine would be liberated less readily than from INH and, therefore, this metabolite would be able to carry out its action in cellular regions other than in the lung, for example in the reticulo-endothelial system. Juhasz et al. (1963) , however, had already obtained tumours of the lymph nodes and leukaemias in " albino " mice by the intraperitoneal administration of INH. A reticulum sarcoma localized in the retroperitoneal lymph node and progressed into an ascitic form which was transplantable (Kendrei and Cossel, 1963 ). An INH induced pulmonary tumour in a male BALB/c/ substrain mouse (Ribacchi et al., 1963) was transplanted and is at present in the 20th generation of homotransplantation.
Clayson et al. (1966) studied the carcinogenic action for the lung in BALB/c/Cb/ Se substrain mice of the following hydrazine derivatives: benzoyl hydrazide, 2-methoxybenzoyl hydrazide, 4-methoxybenzoyl hydrazide, phenylhydrazide hydrochloride and iproniazid. The first three derivatives raised the percentage of mice with pulmonary tumours and the number of pulmonary tumours per mouse above the levels found in untreated animals of the same age. Phenylhydrazide hydrochloride did not increase either the incidence of pulmonary tumours or the number of pulmonary tumours per mouse to the same extent as the first three derivatives, but the malignancy of the tumours produced was more marked. Iproniazid showed no significant carcinogenic action. Histologically the tumours were not much different from those induced by INH and hydrazine, except for a high degree of vascularity. This peculiarity had already been noted in the hepatomas produced by hydrazine sulphate in CBA/Cb/Se substrain mice (Biancifiori et al., 1964a) . Kelly et al. (1964) administered a hydrazine derivative, N-isopropyl-alfa-(2-methylhydrazino)-p-toluamide hydrochloride (MIH), orally and intraperitoneally, to CD2F1 strain mice, and within 15 weeks pulmonary tumours were found in 100% and leukaemias in 50% of the treated mice. Kelly et al. (1964) (Fig. 1) .
INH, Hydrazine and MIH in Rats
Histological examination showed that the tumours were adenocarcinomas (Fig. 2) , anaplastic carcinomas (Fig. 3) and combined squamous and adenocarcinomas (Fig. 4, 5) .
No lung tumours were found in 50 control rats of both sexes which were killed at an average age of about 91 weeks.
Wagner and Moritz (1962) noted that small doses of INH favour the growth of various transplanted tumours in the rat, whereas larger doses inhibit it.
INH in Rabbits Tiboldi et al. (1955) investigated the influence of INH on the growth of the Brown-Pearce tumour in the rabbit. The drug was administered by stomach tube in a dose of 10 mg./kg. per day and it appeared to favour the formation, number and dimensions of the metastases, while it did not influence the mitoses. Pansa and Bikfalvi (1960) studied the effect produced by INH applied directly on the tracheo-bronchial mucosa of the rabbit and observed papilloma-type lesions. These findings, which agree with the papillomatous patterns reported * Albino rats supplied in 1954 by the Chester Beatty Research Institute, London, and kept " at random " in the Division of Cancer Research, Perugia. by others (De Figueiredo and De Paola, 1955) in the bronchial epithelium of tubercular patients treated with INH, have not been confirmed (Viallier and Casanova, 1960) .
The Question of the Chemical Group Responsible As far as identifying the chemical group responsible for the pulmonary tumours which INH is capable of inducing in mice is concerned, three possibilities have been put forward.
According to Mori et al. (1960) and Juhasz et al. (1957) it should prove to be the carbamyl group 0 1 1 (NH2-C-R) They base their contention principally on the fact that the carbamyl group is present in other pulmonary carcinogens as well as in urethane and pyrazinamide. Biancifiori et al. (1963a, b) believe that hydrazine (H2N-NH2) is responsible and point out that hydrazine, when administered alone, has shown clear carcinogenic properties for the lungs.
The importance of hydrazine was confirmed by another experiment in which Biancifiori et al. (1964b) administered ethionamide to BALB/c/Cb/Se substrain mice. This chemical is derived, like INH, from isonicotinic acid but, unlike INH, it does not contain the hydrazine group. Its oral administration, carried out for about 50 weeks broken by rest periods so that the effective number of treatments was 300 and the total dose 600 mg., did not produce tumours of the lung. In this way, formaldehyde, either by itself or as a functional derivative such as hydroxymethylfolinic acid, could lead to the formation of diazomethane. A related mechanism is probably concerned in carcinogenesis by dimethylnitrosamine (Magee, 1963) . If this suggestion is correct, it is necessary to postulate that methylhydrazine, which is not carcinogenic (Kelly et al., 1964) , cannot be oxidized to this methylating agent and that the non-carcinogenic iproniazid (Clayson et al., 1966) Fig. 1 and 4) (Roe et al., 1965) .
It is very strange that there is frequent discussion of the dangers that certain drugs, antiseptics, dyes, flavouring agents, bacteria, bacterial products, chemical additives and pesticides represent for the development of cancer and that there is this sort of conspiracy of silence, not really broken by two letters to the editor and an editorial in two summer issues of the British Medical Journal, 1965, on the carcinogenic potentiality of INH, which is being used more and more indiscriminately, even in children (Roe et al., 1965; Clayson, 1965) .
We must not at this stage give up, without further evidence, the use of such a highly potent drug in the treatment of tuberculosis in adults, but the problem of the carcinogenic potentiality of INH for man has to be faced. It should perhaps be borne in mind also that the same chemical can affect different tissues in different species. There is no certainty that even if INH induces tumours in man these will be leukaemias or carcinomas of the lung and liver as in mice and rats (Clayson, 1965) .
The carcinogenic action of INH in rats and in mice, and the effectiveness of INH in tuberculosis should lead to (a) research on another drug for the treatment of tuberculosis which will be as effective as INH but not a potential carcinogen for man; (b) informing users of this drug that its administration constitutes a potential carcinogenic hazard; (c) withholding INH from children in all circumstances.
CONCLUSIONS
Experimental pathology has shown that INH and some of its allied compounds can induce tumours in the lung, the liver and the lymph glands in the mouse, and in the lung and breast in rats. The problem of the carcinogenic action of these drugs, some of them widely used in man, has scarcely been touched on, and a great deal of time will be needed to establish whether or not there are implications for human pathology.
For the moment we consider it appropriate to associate ourselves with those who wonder: "... is the experimental induction of alveologenic carcinoma by carcinogenic agents a meaningful index of the aetiologic significance of these agents in the pathogenesis of lung cancer in man? " (Kotin and Wisely, 1963) .
Before concluding we should like to draw attention to the frequent observation that in mice treated with INH and hydrazine (Biancifiori et al., 1963a) and with 4-INIP (Milia et al., 1964) , in addition to lung tumours, brown degeneration and hyperplasia of the adrenals were present. Taking into consideration the adrenal modifications observed in the subjects affected with lung cancer (Nichols and Gourley, 1963; Williams and Sommers, 1962 ) the increased excretion of 17-ketosteroids in patients subjected to INH therapy (Krulik and Kohout, 1963) and epithelial broncho-alveolar proliferation in man and in the rabbit after treatment with corticosteroids (Berkheiser, 1963) , the existence of a relationship between the cortico-adrenal glands and lung cancer is possible. SUMMARY Isoniazid (INH) can induce tumours of the lung in " albino ", "dd ", RIII, BALB/c/Cb/Se, C57B1, CBA/Cb/Se mice; in rabbits it enhances the development of the Brown-Pearce tumour and papillomas of the tracheo-bronchial mucosa. It has a growth-inhibiting property in transplanted tumours in rats and reduces metastasizing of Ehrlich's tumour in mice; depending on the time of administration, it influences the take and development of transplanted tumours in mice.
Hydrazine (a hydrolysis product of INH) can induce tumours of the lung in BALB/c/Cb/Se, BALB/c/An/Se, CBA/Cb/Se mice and in Cb London rats. It induces tumours of the liver in CBA/Cb/Se mice.
Hydrazine derivatives: 4-(isonicotinylhydrazone) pimelic acid (4-INIP) can induce tumours of the lung and leukaemias in BALB/c/Cb/Se mice: benzoyl hydrazide, 2-methoxybenzoyl hydrazide, 4-methoxybenzoyl hydrazide and possibly phenylhydrazine hydrochloride can induce tumours of the lung in BALB/c/Cb/Se mice; N-isopropyl-alfa-(2-methylhydrazine)-p-toluamide hydrochloride (MIH) can induce tumours of the lung and leukaemias in CD2F1 mice, and tumours of the mammary gland in Osborne Mendel rats.
Some believe that the carbamyl group 0 1 1 (NH2-C-R) in INH is responsible for the tumours while others (among them the Perugia workers) favour hydrazine (H2N-NH2).
These and other facts suggest that isoniazid and some of its allied compounds may be important in the development of lung tumours in human beings. It is possible that the origin of lung tumours may involve the hormones of the adrenal cortex.
